Skip to main content
. 2026 Mar 11;16(6):828. doi: 10.3390/diagnostics16060828
25FWT 25-Foot Walk Test
9HPT Nine-Hole Peg Test
BREMSO Bayesian Risk Estimate for Multiple Sclerosis at Onset
CC Choriocapillaris
CSF Cerebrospinal Fluid
DCP Deep Capillary Plexus
EDSS Expanded Disability Status Scale
FAZ Foveal Avascular Zone
GCIPL Ganglion Cell Layer–Inner Plexiform Layer
INL Inner Nuclear Layer
IPL Inner Plexiform Layer
MRI Magnetic Resonance Imaging
MoCA Montreal Cognitive Assessment
MOGAD Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
MS Multiple Sclerosis
MS-NON Multiple Sclerosis without Optic Neuritis
MS-ON Multiple Sclerosis with Optic Neuritis
NMOSD Neuromyelitis Optica Spectrum Disorder
OCT Optical Coherence Tomography
OCTA Optical Coherence Tomography Angiography
ON Optic Neuritis
OPL Outer Plexiform Layer
PIRA Progression Independent of Relapse Activity
pwMS Patients with Multiple Sclerosis
RNFL Retinal Nerve Fiber Layer
RoAD Risk of Ambulatory Disability Score
RRMS Relapsing–Remitting Multiple Sclerosis
SCP Superficial Capillary Plexus
SDMT Symbol Digit Modalities Test
VD Vessel Density